Safety of SGLT2 inhibitors versus DPP-4 inhibitors in super-elderly patients (≥ 80 years) with type 2 diabetes: a propensity score-matched cohort study

Authors

Institutions

Publication Details

Journal
Cardiovascular Diabetology – Endocrinology Reports
Published
2026-06-28
DOI
https://doi.org/10.1186/s40842-026-00305-4
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety of SGLT2 inhibitors versus DPP-4 inhibitors in super-elderly patients (≥ 80 years) with type 2 diabetes: a propensity score-matched cohort study

Shankar Kumar Biswas, Bushra Amer, Yashasvi Srivastava, Ayman Hamadttu et al.
Cardiovascular Diabetology – Endocrinology Reports
Diabetes Treatment and Management
article

Safety of SGLT2 inhibitors versus DPP-4 inhibitors in super-elderly patients (≥ 80 years) with type 2 diabetes: a propensity score-matched cohort study

Shankar Kumar Biswas, Bushra Amer, Yashasvi Srivastava, Ayman Hamadttu, Ahmed Wahba
article en

Abstract

No abstract available for this paper.
Cardiovascular Diabetology – Endocrinology ReportsVol. 12(1)
Ivano-Frankivsk National Medical University (UA), Berkshire Medical Center (US), Port Said University (EG), Sudan University of Science and Technology (SD)
Good health and well-being
Openalex Percentile: Top 8%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.